Metraipolis › archive › dc_ff7a73c12f65
CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41628300
- DOI
- 10.1158/2767-9764.crc-25-0399
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:18:21.157Z
- SHA-256 of the archived text
36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4- Stable URL of this page
https://metraipolis.com/documento/dc_ff7a73c12f65
How to cite
CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300 — Europe PMC (en), https://europepmc.org/article/MED/41628300 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff7a73c12f65 (Metraipolis archive dc_ff7a73c12f65, sha256 36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4)
BibTeX
@misc{dcff7a73c12f65,
title = {CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy — Europe PMC PMID:41628300},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41628300},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff7a73c12f65; sha256 36f0f87c6179e9e2b399087c7a6c6afd00086242c89037526afa669a7b2175d4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41628300. Agents can read the archived copy with the MCP tool read_document.